• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle

Eczema drug restores hair growth in teenager with alopecia

The 13-year-old girl, who has alopecia totalis - a total lack of scalp hair - as well as eczema, experienced "significant" hair regrowth while being treated with dupilumab

Joe Mellor by Joe Mellor
2018-10-10 16:33
in Lifestyle
FacebookTwitterLinkedinEmailWhatsapp

Bald people have been given fresh hope after an eczema drug restored hair growth in a teenage girl with long-standing alopecia.

Doctors told how their 13-year-old patient, who has alopecia totalis – a total lack of scalp hair – as well as eczema, experienced “significant” hair regrowth while being treated with dupilumab, a drug marketed under the brand name Dupixent.

The unexpected side-effect came from treatment with dupilumab, which is approved for the treatment of moderate to severe eczema, also called atopic dermatitis.

Study senior author Dr Maryanne Makredes Senna, of Massachusetts General Hospital (MGH) in the US, said: “We were quite surprised since this patient hadn’t grown scalp hair since the age of two, and other treatments that can help with hair loss did not in her case.

“As far as we know, this is the first report of hair regrowth with dupilumab in a patient with any degree of alopecia areata.”

In addition to longstanding alopecia, this girl had also experienced extensive, treatment-resistant eczema since the age of seven months.

Treatment with prednisone and methotrexate, medications that can suppress the overactive immune system, led to limited improvement in her eczema but no hair regrowth and was therefore discontinued.

RelatedPosts

Lucky Numbers and Horoscopes for today 19 May 2022

Top 10 most important work perks

New prostate treatment is being rolled out across the UK

Lucky Numbers and Horoscopes for today 18 May 2022

In July 2017 she began to be treated with weekly injections of dupilumab, which had recently received official approval.

After six weeks of treatment, which led to significant improvement in eczema symptoms, she also noticed that fine light hairs called vellus hairs were appearing on her scalp.

After seven months of dupilumab treatment, the girl had grown a “significant” amount of the pigmented hair that typically grows on the scalp.

Because of a change in her insurance coverage, she had to discontinue dupilumab for a two-month period, during which she noticed shedding of the recently regrown hair.

But after she could resume treatment in April this year, the hair growth resumed and has continued.

Dr Senna explained that dupilumab’s mechanism of targeting a key immune system pathway known to be overactive in eczema could explain its action against alopecia, since recent studies have suggested other elements of the same pathway may induce autoimmune hair loss.

She added: “Right now, it’s hard to know whether dupilumab could induce hair growth in other alopecia patients, but I suspect it may be helpful in patients with extensive active eczema and active alopecia areata.

“We’ve submitted a proposal for a clinical trial using dupilumab in this patient population and hope to be able to investigate it further in the near future.”

The findings were published by JAMA Dermatology,

 

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending
Abdollah

‘Rescue us’: Afghan teacher begs UK to help him escape Taliban

CHOMSKY: “If Corbyn had been elected, Britain would be pursuing a much more sane course”

What If We Got Rid Of Prisons?

More from TLE

Techonomics

Three people gored running with bulls at Pamplona festival

The World in 100 Years’ Time

How to Make: Mac & Wild’s Haggis Pops

Johnson aide should sort out feud with journalists, says Morgan

Coronavirus: Trade ministers warn against barriers

PM urged to reconsider Dfid merger with Foreign Office by charities

Secret UFO files released by the CIA

Brexit bouncer: Govt urged to ‘act fast’ to remedy door staff shortage

Tom Hanks and Audrey Hepburn are Brits top choices to play them in a movie of their life

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.